CYTOKERATIN POSITIVITY IN FINE-NEEDLE ASPIRATES OF MELANOMAS AND SARCOMAS

Citation
Er. Banks et al., CYTOKERATIN POSITIVITY IN FINE-NEEDLE ASPIRATES OF MELANOMAS AND SARCOMAS, Diagnostic cytopathology, 12(3), 1995, pp. 230-233
Citations number
NO
Categorie Soggetti
Medical Laboratory Technology",Pathology
Journal title
ISSN journal
87551039
Volume
12
Issue
3
Year of publication
1995
Pages
230 - 233
Database
ISI
SICI code
8755-1039(1995)12:3<230:CPIFAO>2.0.ZU;2-P
Abstract
Cytokeratin (CK) positivity has been considered a specific marker for epithelial differentiation in cytologic specimens. After observing CK reactivity in fine-needle aspirate (FNA) specimens of melanoma and sar coma, a retrospective study of melanomas and sarcomas was undertaken t o investigate the frequency of anomalous CK staining in these neoplasm s. Cell block sections and/or restrained smears from 36 melanomas and sarcomas were retrospectively stained for CK. An appropriate internal positive control (HMB-45, S100 protein, or vimentin) was also used to insure antigen preservation. Of the smears from 19 melanomas, five rev ealed focal strong CK positivity of neoplastic cells, two cases showed faint or equivocal staining, 11 cases were negative for CK, and one c ould not be interpreted due to inadequate controls. Of the smears from 14 sarcomas, two showed positivity for CK (one fibrosarcoma and one c ondrosarcoma), 11 were negative, and one had inadequate controls. The number of CK positive cells was less than that observed with the appro priate internal positive control antibodies. Destained Papanicolaou sm ears were superior to Diff-Quik smears for retrospective immunocytoche mical stains. Cell block sections from four of the melanomas and one s arcoma demonstrated no aberrant staining. Since cytokeratin positivity occasionally is seen in nonepithelial neoplasms, its presence alone c annot be used to make a definitive diagnosis of carcinoma. Therefore, a panel of immunocytochemical stains should be utilized in diagnosis o f FNA specimens. (C) 1995 Wiley-Liss, Inc.